Articles by Rachel Grabenhofer

  1. Root Causes, Part 1: When Trial Design Locks In Supply Risk 9/8/2026

    This first installment of our new Root Causes video series examines how decisions made long before execution can shape clinical supply outcomes.

  2. Expanded Expertise, Deeper Insight: Clinical Supply Leader Welcomes Two New Advisors 9/4/2026

    Clinical Supply Leader expands its Editorial Advisory Board expertise with the addition of Éamonn McArdle (Allergy Therapeutics) and Juan Hernandez (Bensen Solutions).

  3. Could Smarter Use of Clinical Supply Data Help Avoid Certain Protocol Amendments? 9/3/2026

    Clinical supply data reveals where protocol assumptions break down. Could those lessons help improve protocol design and reduce avoidable amendments?

  4. Can Your Operating Model Grow? Preparing Clinical Supply For What Comes Next 8/10/2026

    Having previously explained why early-stage biotechs should avoid overbuilding, Alicia Collins, of Tune Therapeutics, continues the discussion here in part 2, with thoughts on scaling clinical supply, selecting partners, and preparing for future constraints.

  5. The Biggest Early-Stage Clinical Supply Mistake? Building Too Much, Too Soon. 8/3/2026

    Early-stage biotechs often overbuild systems too soon. Alicia Collins, of Tune Therapeutics, explains why flexibility, simple processes, and realistic assumptions matter most.

  6. How Clinical Supply Is Shaping The Next Generation Of Cell And Gene Therapies 7/31/2026

    From CAR-T to gene editing, clinical supply realities are increasingly influencing therapeutic design, scalability, and patient access.

  7. First Advisors In: Meet Clinical Supply Leader's Inaugural Board Members 7/16/2026

    Clinical Supply Leader unveils its first Editorial Advisory Board, featuring leaders across clinical supply, quality, regulatory affairs, technology, and strategy.

  8. What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 3 – Staying Aligned in a Moving System 6/23/2026

    Even strong plans fail without real-time alignment. As trials evolve, shared visibility, coordinated response, and early supply involvement keep execution on track.

  9. What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 2 – Where Assumptions Break Trials 6/16/2026

    Even strong plans fail without real-time alignment. As trials evolve, shared visibility, coordinated response, and early supply involvement keep execution on track.

  10. What Clinical Wishes Supply Did Better – And How To Close The Gap: Part 1 – The Cost Of Late Involvement 6/9/2026

    Late involvement turns small gaps into costly problems. Bringing clinical supply in early improves planning, communication, and prevents downstream issues.